UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of earliest event reported): July 11, 2006
AmerisourceBergen Corporation
(Exact name of Registrant as specified in its charter)
Delaware | 1-16671 | 23-3079390 | ||
(State or Other Incorporation Jurisdiction of or Organization) |
Commission File Number | (I.R.S. Employer Identification Number) |
1300 Morris Drive Chesterbrook, PA | 19087 | |
(Address of principal executive offices) | (Zip Code) |
Registrants telephone number, including area code: (610) 727-7000
N/A
(Former name or former address, if changed since last report.)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
¨ | Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
¨ | Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
¨ | Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
¨ | Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Item 8.01. Other Events.
On July 11, 2006, AmerisourceBergen Corporation (the Registrant) issued a news release announcing that its wholly owned subsidiary, AmerisourceBergen Canada Corporation, signed an agreement to acquire Rep-Pharm Inc., a pharmaceutical distributor based in Ontario, Canada. A copy of the news release is filed as Exhibit 99.1 to this report and incorporated herein by reference.
Item 9.01. Financial Statements and Exhibits.
(d) | Exhibits. |
99.1 | News Release dated July 11, 2006 |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
AMERISOURCEBERGEN CORPORATION | ||||
Date: July 12, 2006 | By: | /s/ Michael D. DiCandilo | ||
Name: | Michael D. DiCandilo | |||
Title: | Executive Vice President and | |||
Chief Financial Officer |